RESEARCH IN ENGLAND
Search 2,970 registered studies with identifiable England locations in our dated ClinicalTrials.gov snapshot. Explore the study and local recruitment details before contacting the research team.
41 matching studies · ordered by study identifier.
The area filter uses exact source postcodes. Locations without a matched postcode remain in the England-wide results.
NCT01574053 · Observational
Huntington's Disease
Study overall: Recruiting · source record updated 28 February 2024.
21 England locations · 19 explicitly recorded as recruiting.
NCT01804686 · Interventional
Chronic Lymphocytic Leukemia · Small Lymphocytic Lymphoma · Mantle Cell Lymphoma · Follicular Lymphoma · Diffuse Large B-cell Lymphoma · Waldenstrom Macroglobulinemia · Chronic Graft Versus Host Disease
Study overall: Recruiting · source record updated 31 July 2026.
15 England locations · 2 explicitly recorded as recruiting.
NCT02735707 · Interventional
Community-acquired Pneumonia, Influenza, COVID-19
Study overall: Recruiting · source record updated 12 July 2024.
131 England locations · 54 explicitly recorded as recruiting.
NCT03150576 · Interventional
Breast Cancer
Study overall: Recruiting · source record updated 14 November 2022.
26 England locations · 26 explicitly recorded as recruiting.
NCT03288532 · Interventional
Renal Cell Carcinoma
Study overall: Recruiting · source record updated 7 September 2020.
28 England locations · 28 explicitly recorded as recruiting.
NCT03740893 · Interventional
Breast Neoplasm · Triple Negative Breast Cancer (TNBC) · HRD
Study overall: Recruiting · source record updated 11 August 2025.
5 England locations · 2 explicitly recorded as recruiting.
NCT04050345 · Observational
Colorectal Cancer
Study overall: Recruiting · source record updated 14 June 2024.
62 England locations · 57 explicitly recorded as recruiting.
NCT04116502 · Interventional
Polycythemia Vera
Study overall: Recruiting · source record updated 28 April 2026.
40 England locations · 38 explicitly recorded as recruiting.
NCT04204915 · Interventional
Aortic Stenosis
Study overall: Recruiting · source record updated 21 July 2026.
66 England locations · 63 explicitly recorded as recruiting.
NCT04985266 · Interventional
ER+ Breast Cancer · HER2-negative Breast Cancer
Study overall: Recruiting · source record updated 5 December 2024.
24 England locations · 19 explicitly recorded as recruiting.
NCT05020236 · Interventional
Multiple Myeloma
Study overall: Recruiting · source record updated 24 August 2026.
5 England locations · 0 explicitly recorded as recruiting.
NCT05102019 · Interventional
Refractory Angina
Study overall: Recruiting · source record updated 26 August 2026.
20 England locations · 20 explicitly recorded as recruiting.
NCT05441839 · Observational
Heart Failure With Preserved Ejection Fraction (HFpEF)
Study overall: Recruiting · source record updated 6 May 2025.
22 England locations · 22 explicitly recorded as recruiting.
NCT05476913 · Interventional
Stroke, Acute · Venous Thromboembolism · Deep Vein Thrombosis · Pulmonary Embolism
Study overall: Recruiting · source record updated 4 March 2025.
18 England locations · 17 explicitly recorded as recruiting.
NCT05568069 · Interventional
Heart Failure
Study overall: Recruiting · source record updated 16 June 2026.
43 England locations · 40 explicitly recorded as recruiting.
NCT05700149 · Observational
Nodal Marginal Zone Lymphoma
Study overall: Recruiting · source record updated 22 June 2026.
5 England locations · 5 explicitly recorded as recruiting.
NCT06024746 · Interventional
Heart Failure
Study overall: Recruiting · source record updated 10 September 2026.
3 England locations · 3 explicitly recorded as recruiting.
NCT06091254 · Interventional
Follicular Lymphoma (FL)
Study overall: Recruiting · source record updated 10 August 2026.
5 England locations · 4 explicitly recorded as recruiting.
NCT06104566 · Interventional
CLL/SLL
Study overall: Recruiting · source record updated 18 June 2026.
8 England locations · 8 explicitly recorded as recruiting.
NCT06149286 · Interventional
Relapsed/Refractory Follicular Lymphoma · Relapsed/Refractory Marginal Zone Lymphoma (R/R MZL)
Study overall: Recruiting · source record updated 14 August 2026.
9 England locations · 9 explicitly recorded as recruiting.
This is a selected international registry feed, not every study taking place in England. NIHR also lists participation opportunities, including studies that may not appear in this selection.
Source: ClinicalTrials.gov, a United States Government database. Contains OS data © Crown copyright and database right 2026. Contains National Statistics data © Crown copyright and database right 2024; ONS country boundaries (December 2024).
Source processed: 2026-09-10 09:00:04 UTC. Retrieved: 10 September 2026. ClinicalTrials.gov terms.
Selected registered studies with an overall status of Recruiting or Not yet recruiting and at least one England location established by postcode, recorded nation, or source coordinates within the ONS December 2024 boundary. Retained structured fields; omitted descriptions, eligibility text, contacts and non-England locations. Deduplicated identical locations. Linked local care areas only by exact postcode geography. Location points are used for nation filtering, not directions or facility matching.